nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—asthma	0.421	1	CbGaD
Risedronate—PTGS2—Triamcinolone—asthma	0.0771	0.424	CbGbCtD
Risedronate—PTGS2—Betamethasone—asthma	0.0662	0.364	CbGbCtD
Risedronate—PTGS2—Dexamethasone—asthma	0.0385	0.212	CbGbCtD
Risedronate—Histamine Phosphate—HNMT—asthma	0.00455	0.664	CrCbGaD
Risedronate—FDPS—respiratory system—asthma	0.00318	0.114	CbGeAlD
Risedronate—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—ALOX15—asthma	0.00301	0.0574	CbGpPWpGaD
Risedronate—FDPS—adrenal cortex—asthma	0.00267	0.0957	CbGeAlD
Risedronate—FDPS—bronchus—asthma	0.00262	0.0938	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—asthma	0.00256	0.0918	CbGeAlD
Risedronate—FDPS—cardiovascular system—asthma	0.00244	0.0873	CbGeAlD
Risedronate—FDPS—trachea—asthma	0.00235	0.0843	CbGeAlD
Risedronate—Histamine Phosphate—HRH4—asthma	0.0023	0.336	CrCbGaD
Risedronate—FDPS—Activation of gene expression by SREBF (SREBP)—CARM1—asthma	0.00223	0.0426	CbGpPWpGaD
Risedronate—FDPS—adrenal gland—asthma	0.00193	0.0691	CbGeAlD
Risedronate—PTGS2—Eicosanoid Synthesis—LTC4S—asthma	0.00182	0.0348	CbGpPWpGaD
Risedronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—CARM1—asthma	0.00178	0.034	CbGpPWpGaD
Risedronate—FDPS—lung—asthma	0.00169	0.0605	CbGeAlD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—SCGB1A1—asthma	0.00162	0.0309	CbGpPWpGaD
Risedronate—PTGS2—Eicosanoid Synthesis—LTA4H—asthma	0.00158	0.0301	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—asthma	0.00135	0.0257	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—HSD11B2—asthma	0.00132	0.0252	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PTGDR—asthma	0.00123	0.0234	CbGpPWpGaD
Risedronate—PTGS2—respiratory system—asthma	0.00122	0.0437	CbGeAlD
Risedronate—PTGS2—adrenal cortex—asthma	0.00102	0.0367	CbGeAlD
Risedronate—PTGS2—epithelium—asthma	0.00102	0.0365	CbGeAlD
Risedronate—PTGS2—Arachidonic acid metabolism—LTC4S—asthma	0.00101	0.0193	CbGpPWpGaD
Risedronate—PTGS2—bronchus—asthma	0.001	0.036	CbGeAlD
Risedronate—PTGS2—Eicosanoid Synthesis—ALOX5AP—asthma	0.000992	0.0189	CbGpPWpGaD
Risedronate—PTGS2—Eicosanoid Synthesis—ALOX15—asthma	0.000992	0.0189	CbGpPWpGaD
Risedronate—PTGS2—smooth muscle tissue—asthma	0.000982	0.0352	CbGeAlD
Risedronate—PTGS2—cardiovascular system—asthma	0.000934	0.0335	CbGeAlD
Risedronate—PTGS2—trachea—asthma	0.000901	0.0323	CbGeAlD
Risedronate—PTGS2—Arachidonic acid metabolism—LTA4H—asthma	0.000878	0.0168	CbGpPWpGaD
Risedronate—PTGS2—Eicosanoid Synthesis—ALOX5—asthma	0.000843	0.0161	CbGpPWpGaD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—asthma	0.000831	0.0159	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—asthma	0.000816	0.0156	CbGpPWpGaD
Risedronate—PTGS2—adrenal gland—asthma	0.000739	0.0265	CbGeAlD
Risedronate—PTGS2—Fluocinonide—Ciclesonide—asthma	0.000678	0.111	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Fluticasone furoate—asthma	0.000665	0.109	CbGdCrCtD
Risedronate—PTGS2—lung—asthma	0.000647	0.0232	CbGeAlD
Risedronate—PTGS2—Fluocinonide—Fluticasone Propionate—asthma	0.00062	0.101	CbGdCrCtD
Risedronate—PTGS2—Overview of nanoparticle effects—HMOX1—asthma	0.000605	0.0115	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000604	0.0115	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—EDNRB—asthma	0.000581	0.0111	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—ALOX15—asthma	0.000551	0.0105	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—ALOX5AP—asthma	0.000551	0.0105	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000524	0.01	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—asthma	0.000511	0.00975	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—asthma	0.000485	0.00926	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—PDGFB—asthma	0.000485	0.00925	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—CRP—asthma	0.000474	0.00904	CbGpPWpGaD
Risedronate—PTGS2—Arachidonic acid metabolism—ALOX5—asthma	0.000469	0.00895	CbGpPWpGaD
Risedronate—PTGS2—Fluocinonide—Beclomethasone—asthma	0.000456	0.0745	CbGdCrCtD
Risedronate—PTGS2—Overview of nanoparticle effects—FN1—asthma	0.000437	0.00834	CbGpPWpGaD
Risedronate—PTGS2—Fluocinonide—Budesonide—asthma	0.000437	0.0714	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Flunisolide—asthma	0.000431	0.0705	CbGdCrCtD
Risedronate—PTGS2—Spinal Cord Injury—LTB4R—asthma	0.000411	0.00784	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—asthma	0.000402	0.00766	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Fluticasone furoate—asthma	0.000401	0.0656	CbGdCrCtD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—asthma	0.000397	0.00758	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—asthma	0.000395	0.00755	CbGpPWpGaD
Risedronate—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—asthma	0.000391	0.00746	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—asthma	0.000391	0.00746	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ARG1—asthma	0.000386	0.00737	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—GATA3—asthma	0.000375	0.00715	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NQO1—asthma	0.000362	0.00691	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—asthma	0.000358	0.00683	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—asthma	0.000355	0.00678	CbGpPWpGaD
Risedronate—PTGS2—Fluocinonide—Mometasone—asthma	0.000353	0.0577	CbGdCrCtD
Risedronate—PTGS2—S1P1 pathway—RHOA—asthma	0.000351	0.00669	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALOX5AP—asthma	0.000351	0.00669	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—asthma	0.000346	0.00659	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—BCL2—asthma	0.000334	0.00638	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—asthma	0.000334	0.00637	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—asthma	0.000331	0.00631	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALOX15—asthma	0.000329	0.00628	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	0.000329	0.00628	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MIF—asthma	0.000322	0.00615	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—MYB—asthma	0.000321	0.00612	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CHAT—asthma	0.000314	0.00599	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—CXCL8—asthma	0.000308	0.00588	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALOX5—asthma	0.000298	0.00569	CbGpPWpGaD
Risedronate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—asthma	0.000287	0.00548	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALOX5—asthma	0.00028	0.00534	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1R1—asthma	0.000277	0.00529	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Beclomethasone—asthma	0.000275	0.0449	CbGdCrCtD
Risedronate—FDPS—Metabolism—LTC4S—asthma	0.000269	0.00513	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CARM1—asthma	0.000267	0.00509	CbGpPWpGaD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—asthma	0.000265	0.00506	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Flunisolide—asthma	0.00026	0.0425	CbGdCrCtD
Risedronate—PTGS2—Arachidonic acid metabolism—PLA2G4A—asthma	0.00026	0.00496	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—asthma	0.00026	0.00496	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—asthma	0.000257	0.0049	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—asthma	0.000253	0.00482	CbGpPWpGaD
Risedronate—PTGS2—S1P1 pathway—VEGFA—asthma	0.00025	0.00477	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—GATA3—asthma	0.000247	0.00472	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—asthma	0.000236	0.00451	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—C5—asthma	0.000236	0.0045	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TACR1—asthma	0.000236	0.0045	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LTA4H—asthma	0.000233	0.00445	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CDK2—asthma	0.000232	0.00442	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—asthma	0.000232	0.00442	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—asthma	0.000214	0.00409	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Mometasone—asthma	0.000213	0.0348	CbGdCrCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—RAD50—asthma	0.000212	0.00404	CbGpPWpGaD
Risedronate—PTGS2—Fluocinonide—Methylprednisolone—asthma	0.000211	0.0345	CbGdCrCtD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—asthma	0.00021	0.004	CbGpPWpGaD
Risedronate—PTGS2—Fluocinonide—Dexamethasone—asthma	0.000208	0.0339	CbGdCrCtD
Risedronate—PTGS2—Fluocinonide—Betamethasone—asthma	0.000208	0.0339	CbGdCrCtD
Risedronate—FDPS—Metabolism—ARG1—asthma	0.000204	0.00389	CbGpPWpGaD
Risedronate—PTGS2—Fluocinonide—Triamcinolone—asthma	0.000203	0.0332	CbGdCrCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—asthma	0.000189	0.0036	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALDH7A1—asthma	0.000184	0.00352	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ARG2—asthma	0.000177	0.00337	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CAT—asthma	0.000175	0.00334	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—asthma	0.000173	0.0033	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—GSTM1—asthma	0.000172	0.00327	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS1—asthma	0.000168	0.00321	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	0.000155	0.00296	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—asthma	0.000153	0.00291	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CXCL10—asthma	0.000152	0.00291	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALOX15—asthma	0.000147	0.0028	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALOX5AP—asthma	0.000147	0.0028	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LTC4S—asthma	0.000145	0.00276	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—asthma	0.000142	0.00271	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CHAT—asthma	0.00014	0.00267	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CRP—asthma	0.000139	0.00265	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—BDNF—asthma	0.000137	0.00261	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—asthma	0.000136	0.00259	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ICAM1—asthma	0.000128	0.00244	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Methylprednisolone—asthma	0.000127	0.0208	CbGdCrCtD
Risedronate—PTGS2—Spinal Cord Injury—IL4—asthma	0.000127	0.00243	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—asthma	0.000125	0.00239	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Dexamethasone—asthma	0.000125	0.0205	CbGdCrCtD
Risedronate—PTGS2—Fluticasone Propionate—Betamethasone—asthma	0.000125	0.0205	CbGdCrCtD
Risedronate—FDPS—Metabolism—ALOX5—asthma	0.000125	0.00238	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—asthma	0.000123	0.00235	CbGpPWpGaD
Risedronate—PTGS2—Fluticasone Propionate—Triamcinolone—asthma	0.000122	0.02	CbGdCrCtD
Risedronate—FDPS—Metabolism—CARM1—asthma	0.000119	0.00227	CbGpPWpGaD
Risedronate—FDPS—Metabolism—DCN—asthma	0.000117	0.00224	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—asthma	0.000115	0.0022	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CCL2—asthma	0.000114	0.00218	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALDH2—asthma	0.000114	0.00217	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—asthma	0.000113	0.00216	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—asthma	0.000111	0.00212	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—POMC—asthma	0.00011	0.00209	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CDK2—asthma	0.000109	0.00208	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTT1—asthma	0.000108	0.00207	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—LEP—asthma	0.000108	0.00205	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SERPINE1—asthma	0.000107	0.00204	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—asthma	0.000107	0.00203	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—asthma	0.000106	0.00202	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TLR4—asthma	0.000105	0.00201	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—BCL2—asthma	0.000102	0.00194	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—asthma	0.000102	0.00194	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ICAM1—asthma	0.000101	0.00193	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—asthma	0.0001	0.00191	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—asthma	9.99e-05	0.00191	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—asthma	9.89e-05	0.00189	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—CD4—asthma	9.74e-05	0.00186	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IFNG—asthma	9.72e-05	0.00185	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—asthma	9.31e-05	0.00178	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCL2—asthma	9.04e-05	0.00172	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NQO1—asthma	9.01e-05	0.00172	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—asthma	8.89e-05	0.0017	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ADCY2—asthma	8.81e-05	0.00168	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—asthma	8.74e-05	0.00167	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—asthma	8.67e-05	0.00165	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—RHOA—asthma	8.14e-05	0.00155	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	7.88e-05	0.0015	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—asthma	7.88e-05	0.0015	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IFNG—asthma	7.69e-05	0.00147	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—asthma	7.62e-05	0.00145	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CHAT—asthma	7.52e-05	0.00143	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTP1—asthma	7.51e-05	0.00143	CbGpPWpGaD
Risedronate—Rash—Formoterol—asthma	7.46e-05	0.000246	CcSEcCtD
Risedronate—Rash—Arformoterol—asthma	7.46e-05	0.000246	CcSEcCtD
Risedronate—Mediastinal disorder—Methylprednisolone—asthma	7.45e-05	0.000245	CcSEcCtD
Risedronate—Dermatitis—Arformoterol—asthma	7.45e-05	0.000245	CcSEcCtD
Risedronate—Dermatitis—Formoterol—asthma	7.45e-05	0.000245	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CDK2—asthma	7.42e-05	0.00142	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMOX1—asthma	7.41e-05	0.00141	CbGpPWpGaD
Risedronate—Headache—Formoterol—asthma	7.41e-05	0.000244	CcSEcCtD
Risedronate—Headache—Arformoterol—asthma	7.41e-05	0.000244	CcSEcCtD
Risedronate—Arrhythmia—Triamcinolone—asthma	7.41e-05	0.000244	CcSEcCtD
Risedronate—Diarrhoea—Budesonide—asthma	7.4e-05	0.000244	CcSEcCtD
Risedronate—FDPS—Metabolism—ITPR1—asthma	7.39e-05	0.00141	CbGpPWpGaD
Risedronate—Arrhythmia—Methylprednisolone—asthma	7.39e-05	0.000243	CcSEcCtD
Risedronate—Dizziness—Salbutamol—asthma	7.38e-05	0.000243	CcSEcCtD
Risedronate—Vomiting—Montelukast—asthma	7.36e-05	0.000242	CcSEcCtD
Risedronate—FDPS—Metabolism—CAT—asthma	7.31e-05	0.00139	CbGpPWpGaD
Risedronate—Rash—Montelukast—asthma	7.3e-05	0.00024	CcSEcCtD
Risedronate—Dermatitis—Montelukast—asthma	7.3e-05	0.00024	CcSEcCtD
Risedronate—Depression—Prednisone—asthma	7.28e-05	0.00024	CcSEcCtD
Risedronate—Headache—Montelukast—asthma	7.26e-05	0.000239	CcSEcCtD
Risedronate—Mental disorder—Methylprednisolone—asthma	7.25e-05	0.000239	CcSEcCtD
Risedronate—Malnutrition—Methylprednisolone—asthma	7.2e-05	0.000237	CcSEcCtD
Risedronate—Angioedema—Prednisolone—asthma	7.17e-05	0.000236	CcSEcCtD
Risedronate—Dizziness—Budesonide—asthma	7.15e-05	0.000236	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—CXCL8—asthma	7.15e-05	0.00136	CbGpPWpGaD
Risedronate—Vomiting—Salbutamol—asthma	7.1e-05	0.000234	CcSEcCtD
Risedronate—Vertigo—Prednisolone—asthma	7.05e-05	0.000232	CcSEcCtD
Risedronate—Rash—Salbutamol—asthma	7.04e-05	0.000232	CcSEcCtD
Risedronate—Syncope—Prednisolone—asthma	7.04e-05	0.000232	CcSEcCtD
Risedronate—Dermatitis—Salbutamol—asthma	7.03e-05	0.000232	CcSEcCtD
Risedronate—Eye disorder—Betamethasone—asthma	7.03e-05	0.000231	CcSEcCtD
Risedronate—Eye disorder—Dexamethasone—asthma	7.03e-05	0.000231	CcSEcCtD
Risedronate—Nausea—Formoterol—asthma	7.02e-05	0.000231	CcSEcCtD
Risedronate—Nausea—Arformoterol—asthma	7.02e-05	0.000231	CcSEcCtD
Risedronate—Angioedema—Hydrocortisone—asthma	7e-05	0.000231	CcSEcCtD
Risedronate—Headache—Salbutamol—asthma	6.99e-05	0.00023	CcSEcCtD
Risedronate—Back pain—Triamcinolone—asthma	6.98e-05	0.00023	CcSEcCtD
Risedronate—FDPS—Metabolism—PLA2G4A—asthma	6.9e-05	0.00132	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTM1—asthma	6.9e-05	0.00132	CbGpPWpGaD
Risedronate—Loss of consciousness—Prednisolone—asthma	6.9e-05	0.000227	CcSEcCtD
Risedronate—Vertigo—Hydrocortisone—asthma	6.89e-05	0.000227	CcSEcCtD
Risedronate—Nausea—Montelukast—asthma	6.88e-05	0.000227	CcSEcCtD
Risedronate—Vomiting—Budesonide—asthma	6.88e-05	0.000226	CcSEcCtD
Risedronate—Syncope—Hydrocortisone—asthma	6.87e-05	0.000226	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—asthma	6.86e-05	0.00131	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL2—asthma	6.83e-05	0.0013	CbGpPWpGaD
Risedronate—Angiopathy—Betamethasone—asthma	6.82e-05	0.000225	CcSEcCtD
Risedronate—Angiopathy—Dexamethasone—asthma	6.82e-05	0.000225	CcSEcCtD
Risedronate—Rash—Budesonide—asthma	6.82e-05	0.000225	CcSEcCtD
Risedronate—Dermatitis—Budesonide—asthma	6.81e-05	0.000224	CcSEcCtD
Risedronate—Headache—Budesonide—asthma	6.78e-05	0.000223	CcSEcCtD
Risedronate—Hypertension—Prednisolone—asthma	6.77e-05	0.000223	CcSEcCtD
Risedronate—Loss of consciousness—Hydrocortisone—asthma	6.74e-05	0.000222	CcSEcCtD
Risedronate—Arrhythmia—Betamethasone—asthma	6.72e-05	0.000221	CcSEcCtD
Risedronate—Arrhythmia—Dexamethasone—asthma	6.72e-05	0.000221	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—asthma	6.7e-05	0.00128	CbGpPWpGaD
Risedronate—Nausea—Salbutamol—asthma	6.63e-05	0.000218	CcSEcCtD
Risedronate—Hypertension—Hydrocortisone—asthma	6.62e-05	0.000218	CcSEcCtD
Risedronate—Angioedema—Triamcinolone—asthma	6.59e-05	0.000217	CcSEcCtD
Risedronate—Haemoglobin—Prednisone—asthma	6.58e-05	0.000217	CcSEcCtD
Risedronate—Angioedema—Methylprednisolone—asthma	6.58e-05	0.000217	CcSEcCtD
Risedronate—Haemorrhage—Prednisone—asthma	6.55e-05	0.000216	CcSEcCtD
Risedronate—Myalgia—Hydrocortisone—asthma	6.52e-05	0.000215	CcSEcCtD
Risedronate—Anxiety—Hydrocortisone—asthma	6.5e-05	0.000214	CcSEcCtD
Risedronate—Vertigo—Triamcinolone—asthma	6.48e-05	0.000213	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	6.48e-05	0.000213	CcSEcCtD
Risedronate—Syncope—Triamcinolone—asthma	6.47e-05	0.000213	CcSEcCtD
Risedronate—Vertigo—Methylprednisolone—asthma	6.47e-05	0.000213	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—asthma	6.46e-05	0.00123	CbGpPWpGaD
Risedronate—Syncope—Methylprednisolone—asthma	6.46e-05	0.000213	CcSEcCtD
Risedronate—PTGS2—Metabolism—LTC4S—asthma	6.45e-05	0.00123	CbGpPWpGaD
Risedronate—Connective tissue disorder—Prednisone—asthma	6.44e-05	0.000212	CcSEcCtD
Risedronate—Nausea—Budesonide—asthma	6.42e-05	0.000212	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CARM1—asthma	6.39e-05	0.00122	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPP2CA—asthma	6.36e-05	0.00121	CbGpPWpGaD
Risedronate—Loss of consciousness—Triamcinolone—asthma	6.34e-05	0.000209	CcSEcCtD
Risedronate—Loss of consciousness—Methylprednisolone—asthma	6.33e-05	0.000208	CcSEcCtD
Risedronate—Shock—Prednisolone—asthma	6.3e-05	0.000207	CcSEcCtD
Risedronate—Cough—Triamcinolone—asthma	6.3e-05	0.000207	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—asthma	6.29e-05	0.0012	CbGpPWpGaD
Risedronate—Hypertension—Triamcinolone—asthma	6.23e-05	0.000205	CcSEcCtD
Risedronate—Hypertension—Methylprednisolone—asthma	6.22e-05	0.000205	CcSEcCtD
Risedronate—Infection—Hydrocortisone—asthma	6.21e-05	0.000205	CcSEcCtD
Risedronate—Shock—Hydrocortisone—asthma	6.15e-05	0.000203	CcSEcCtD
Risedronate—Myalgia—Triamcinolone—asthma	6.14e-05	0.000202	CcSEcCtD
Risedronate—Nervous system disorder—Hydrocortisone—asthma	6.13e-05	0.000202	CcSEcCtD
Risedronate—Myalgia—Methylprednisolone—asthma	6.13e-05	0.000202	CcSEcCtD
Risedronate—Arthralgia—Methylprednisolone—asthma	6.13e-05	0.000202	CcSEcCtD
Risedronate—Eye disorder—Prednisone—asthma	6.12e-05	0.000202	CcSEcCtD
Risedronate—Anxiety—Methylprednisolone—asthma	6.11e-05	0.000201	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	6.09e-05	0.0002	CcSEcCtD
Risedronate—Skin disorder—Hydrocortisone—asthma	6.08e-05	0.0002	CcSEcCtD
Risedronate—Dry mouth—Triamcinolone—asthma	6.01e-05	0.000198	CcSEcCtD
Risedronate—Angioedema—Dexamethasone—asthma	5.98e-05	0.000197	CcSEcCtD
Risedronate—Angioedema—Betamethasone—asthma	5.98e-05	0.000197	CcSEcCtD
Risedronate—Angiopathy—Prednisone—asthma	5.94e-05	0.000196	CcSEcCtD
Risedronate—Immune system disorder—Prednisone—asthma	5.92e-05	0.000195	CcSEcCtD
Risedronate—Vertigo—Betamethasone—asthma	5.88e-05	0.000194	CcSEcCtD
Risedronate—Vertigo—Dexamethasone—asthma	5.88e-05	0.000194	CcSEcCtD
Risedronate—Syncope—Dexamethasone—asthma	5.87e-05	0.000193	CcSEcCtD
Risedronate—Syncope—Betamethasone—asthma	5.87e-05	0.000193	CcSEcCtD
Risedronate—Arrhythmia—Prednisone—asthma	5.85e-05	0.000193	CcSEcCtD
Risedronate—Infection—Triamcinolone—asthma	5.85e-05	0.000193	CcSEcCtD
Risedronate—Infection—Methylprednisolone—asthma	5.84e-05	0.000192	CcSEcCtD
Risedronate—Shock—Triamcinolone—asthma	5.79e-05	0.000191	CcSEcCtD
Risedronate—Insomnia—Prednisolone—asthma	5.79e-05	0.000191	CcSEcCtD
Risedronate—Shock—Methylprednisolone—asthma	5.78e-05	0.00019	CcSEcCtD
Risedronate—Nervous system disorder—Methylprednisolone—asthma	5.76e-05	0.00019	CcSEcCtD
Risedronate—Loss of consciousness—Betamethasone—asthma	5.75e-05	0.000189	CcSEcCtD
Risedronate—Loss of consciousness—Dexamethasone—asthma	5.75e-05	0.000189	CcSEcCtD
Risedronate—Paraesthesia—Prednisolone—asthma	5.75e-05	0.000189	CcSEcCtD
Risedronate—Mental disorder—Prednisone—asthma	5.74e-05	0.000189	CcSEcCtD
Risedronate—Skin disorder—Methylprednisolone—asthma	5.71e-05	0.000188	CcSEcCtD
Risedronate—Malnutrition—Prednisone—asthma	5.7e-05	0.000188	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Hydrocortisone—asthma	5.7e-05	0.000188	CcSEcCtD
Risedronate—Insomnia—Hydrocortisone—asthma	5.66e-05	0.000186	CcSEcCtD
Risedronate—Hypertension—Dexamethasone—asthma	5.65e-05	0.000186	CcSEcCtD
Risedronate—Hypertension—Betamethasone—asthma	5.65e-05	0.000186	CcSEcCtD
Risedronate—Paraesthesia—Hydrocortisone—asthma	5.62e-05	0.000185	CcSEcCtD
Risedronate—PTGS2—Metabolism—LTA4H—asthma	5.59e-05	0.00107	CbGpPWpGaD
Risedronate—Myalgia—Betamethasone—asthma	5.57e-05	0.000184	CcSEcCtD
Risedronate—Myalgia—Dexamethasone—asthma	5.57e-05	0.000184	CcSEcCtD
Risedronate—Anxiety—Dexamethasone—asthma	5.55e-05	0.000183	CcSEcCtD
Risedronate—Anxiety—Betamethasone—asthma	5.55e-05	0.000183	CcSEcCtD
Risedronate—Dyspepsia—Hydrocortisone—asthma	5.51e-05	0.000181	CcSEcCtD
Risedronate—Pain—Prednisolone—asthma	5.48e-05	0.00018	CcSEcCtD
Risedronate—Gastrointestinal disorder—Hydrocortisone—asthma	5.4e-05	0.000178	CcSEcCtD
Risedronate—Fatigue—Hydrocortisone—asthma	5.39e-05	0.000178	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Triamcinolone—asthma	5.37e-05	0.000177	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Methylprednisolone—asthma	5.35e-05	0.000176	CcSEcCtD
Risedronate—Pain—Hydrocortisone—asthma	5.35e-05	0.000176	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—asthma	5.33e-05	0.00102	CbGpPWpGaD
Risedronate—Insomnia—Triamcinolone—asthma	5.33e-05	0.000175	CcSEcCtD
Risedronate—Insomnia—Methylprednisolone—asthma	5.31e-05	0.000175	CcSEcCtD
Risedronate—Infection—Betamethasone—asthma	5.31e-05	0.000175	CcSEcCtD
Risedronate—Infection—Dexamethasone—asthma	5.31e-05	0.000175	CcSEcCtD
Risedronate—Paraesthesia—Triamcinolone—asthma	5.29e-05	0.000174	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—asthma	5.28e-05	0.00101	CbGpPWpGaD
Risedronate—Paraesthesia—Methylprednisolone—asthma	5.28e-05	0.000174	CcSEcCtD
Risedronate—Anaemia—Prednisone—asthma	5.27e-05	0.000174	CcSEcCtD
Risedronate—Shock—Dexamethasone—asthma	5.26e-05	0.000173	CcSEcCtD
Risedronate—Shock—Betamethasone—asthma	5.26e-05	0.000173	CcSEcCtD
Risedronate—Dyspnoea—Triamcinolone—asthma	5.25e-05	0.000173	CcSEcCtD
Risedronate—Nervous system disorder—Betamethasone—asthma	5.24e-05	0.000173	CcSEcCtD
Risedronate—Nervous system disorder—Dexamethasone—asthma	5.24e-05	0.000173	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—EGFR—asthma	5.22e-05	0.000997	CbGpPWpGaD
Risedronate—Angioedema—Prednisone—asthma	5.21e-05	0.000172	CcSEcCtD
Risedronate—Dyspepsia—Triamcinolone—asthma	5.18e-05	0.000171	CcSEcCtD
Risedronate—Dyspepsia—Methylprednisolone—asthma	5.17e-05	0.00017	CcSEcCtD
Risedronate—Vertigo—Prednisone—asthma	5.12e-05	0.000169	CcSEcCtD
Risedronate—Gastrointestinal pain—Hydrocortisone—asthma	5.11e-05	0.000168	CcSEcCtD
Risedronate—Syncope—Prednisone—asthma	5.11e-05	0.000168	CcSEcCtD
Risedronate—Urticaria—Prednisolone—asthma	5.09e-05	0.000168	CcSEcCtD
Risedronate—Fatigue—Triamcinolone—asthma	5.08e-05	0.000167	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—asthma	5.08e-05	0.000969	CbGpPWpGaD
Risedronate—Fatigue—Methylprednisolone—asthma	5.07e-05	0.000167	CcSEcCtD
Risedronate—Pain—Triamcinolone—asthma	5.04e-05	0.000166	CcSEcCtD
Risedronate—Loss of consciousness—Prednisone—asthma	5.01e-05	0.000165	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—TNF—asthma	4.97e-05	0.000949	CbGpPWpGaD
Risedronate—Urticaria—Hydrocortisone—asthma	4.97e-05	0.000164	CcSEcCtD
Risedronate—Abdominal pain—Hydrocortisone—asthma	4.94e-05	0.000163	CcSEcCtD
Risedronate—Body temperature increased—Hydrocortisone—asthma	4.94e-05	0.000163	CcSEcCtD
Risedronate—Hypertension—Prednisone—asthma	4.92e-05	0.000162	CcSEcCtD
Risedronate—PTGS2—Metabolism—ARG1—asthma	4.88e-05	0.000932	CbGpPWpGaD
Risedronate—FDPS—Metabolism—POMC—asthma	4.88e-05	0.000931	CbGpPWpGaD
Risedronate—Musculoskeletal discomfort—Dexamethasone—asthma	4.87e-05	0.00016	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Betamethasone—asthma	4.87e-05	0.00016	CcSEcCtD
Risedronate—Arthralgia—Prednisone—asthma	4.85e-05	0.00016	CcSEcCtD
Risedronate—Myalgia—Prednisone—asthma	4.85e-05	0.00016	CcSEcCtD
Risedronate—Anxiety—Prednisone—asthma	4.84e-05	0.000159	CcSEcCtD
Risedronate—Insomnia—Dexamethasone—asthma	4.83e-05	0.000159	CcSEcCtD
Risedronate—Insomnia—Betamethasone—asthma	4.83e-05	0.000159	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.82e-05	0.000159	CcSEcCtD
Risedronate—Gastrointestinal pain—Methylprednisolone—asthma	4.81e-05	0.000158	CcSEcCtD
Risedronate—Paraesthesia—Betamethasone—asthma	4.8e-05	0.000158	CcSEcCtD
Risedronate—Paraesthesia—Dexamethasone—asthma	4.8e-05	0.000158	CcSEcCtD
Risedronate—Hypersensitivity—Prednisolone—asthma	4.72e-05	0.000155	CcSEcCtD
Risedronate—Dyspepsia—Dexamethasone—asthma	4.7e-05	0.000155	CcSEcCtD
Risedronate—Dyspepsia—Betamethasone—asthma	4.7e-05	0.000155	CcSEcCtD
Risedronate—Urticaria—Triamcinolone—asthma	4.68e-05	0.000154	CcSEcCtD
Risedronate—Urticaria—Methylprednisolone—asthma	4.67e-05	0.000154	CcSEcCtD
Risedronate—Body temperature increased—Triamcinolone—asthma	4.66e-05	0.000153	CcSEcCtD
Risedronate—Abdominal pain—Methylprednisolone—asthma	4.65e-05	0.000153	CcSEcCtD
Risedronate—Infection—Prednisone—asthma	4.62e-05	0.000152	CcSEcCtD
Risedronate—Gastrointestinal disorder—Betamethasone—asthma	4.61e-05	0.000152	CcSEcCtD
Risedronate—Gastrointestinal disorder—Dexamethasone—asthma	4.61e-05	0.000152	CcSEcCtD
Risedronate—Hypersensitivity—Hydrocortisone—asthma	4.61e-05	0.000152	CcSEcCtD
Risedronate—Fatigue—Dexamethasone—asthma	4.61e-05	0.000152	CcSEcCtD
Risedronate—Fatigue—Betamethasone—asthma	4.61e-05	0.000152	CcSEcCtD
Risedronate—Shock—Prednisone—asthma	4.58e-05	0.000151	CcSEcCtD
Risedronate—Pain—Betamethasone—asthma	4.57e-05	0.00015	CcSEcCtD
Risedronate—Pain—Dexamethasone—asthma	4.57e-05	0.00015	CcSEcCtD
Risedronate—Nervous system disorder—Prednisone—asthma	4.56e-05	0.00015	CcSEcCtD
Risedronate—Skin disorder—Prednisone—asthma	4.52e-05	0.000149	CcSEcCtD
Risedronate—Asthenia—Hydrocortisone—asthma	4.49e-05	0.000148	CcSEcCtD
Risedronate—FDPS—Metabolism—ALB—asthma	4.45e-05	0.000849	CbGpPWpGaD
Risedronate—Pruritus—Hydrocortisone—asthma	4.43e-05	0.000146	CcSEcCtD
Risedronate—PTGS2—Metabolism—ALDH7A1—asthma	4.42e-05	0.000843	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—asthma	4.37e-05	0.000834	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Betamethasone—asthma	4.37e-05	0.000144	CcSEcCtD
Risedronate—Gastrointestinal pain—Dexamethasone—asthma	4.37e-05	0.000144	CcSEcCtD
Risedronate—Hypersensitivity—Triamcinolone—asthma	4.34e-05	0.000143	CcSEcCtD
Risedronate—Hypersensitivity—Methylprednisolone—asthma	4.33e-05	0.000143	CcSEcCtD
Risedronate—Diarrhoea—Hydrocortisone—asthma	4.28e-05	0.000141	CcSEcCtD
Risedronate—FDPS—Metabolism—NOS3—asthma	4.26e-05	0.000812	CbGpPWpGaD
Risedronate—Urticaria—Dexamethasone—asthma	4.25e-05	0.00014	CcSEcCtD
Risedronate—Urticaria—Betamethasone—asthma	4.25e-05	0.00014	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Prednisone—asthma	4.24e-05	0.00014	CcSEcCtD
Risedronate—PTGS2—Metabolism—ARG2—asthma	4.24e-05	0.000808	CbGpPWpGaD
Risedronate—Dizziness—Prednisolone—asthma	4.23e-05	0.000139	CcSEcCtD
Risedronate—Asthenia—Triamcinolone—asthma	4.23e-05	0.000139	CcSEcCtD
Risedronate—Abdominal pain—Betamethasone—asthma	4.22e-05	0.000139	CcSEcCtD
Risedronate—Body temperature increased—Betamethasone—asthma	4.22e-05	0.000139	CcSEcCtD
Risedronate—Body temperature increased—Dexamethasone—asthma	4.22e-05	0.000139	CcSEcCtD
Risedronate—Abdominal pain—Dexamethasone—asthma	4.22e-05	0.000139	CcSEcCtD
Risedronate—Asthenia—Methylprednisolone—asthma	4.22e-05	0.000139	CcSEcCtD
Risedronate—Insomnia—Prednisone—asthma	4.21e-05	0.000139	CcSEcCtD
Risedronate—Paraesthesia—Prednisone—asthma	4.18e-05	0.000138	CcSEcCtD
Risedronate—Pruritus—Triamcinolone—asthma	4.17e-05	0.000137	CcSEcCtD
Risedronate—Pruritus—Methylprednisolone—asthma	4.16e-05	0.000137	CcSEcCtD
Risedronate—Dizziness—Hydrocortisone—asthma	4.14e-05	0.000136	CcSEcCtD
Risedronate—Dyspepsia—Prednisone—asthma	4.1e-05	0.000135	CcSEcCtD
Risedronate—Rash—Prednisolone—asthma	4.04e-05	0.000133	CcSEcCtD
Risedronate—Dermatitis—Prednisolone—asthma	4.03e-05	0.000133	CcSEcCtD
Risedronate—Diarrhoea—Methylprednisolone—asthma	4.02e-05	0.000132	CcSEcCtD
Risedronate—PTGS2—Spinal Cord Injury—IL6—asthma	4.01e-05	0.000766	CbGpPWpGaD
Risedronate—Fatigue—Prednisone—asthma	4.01e-05	0.000132	CcSEcCtD
Risedronate—Headache—Prednisolone—asthma	4.01e-05	0.000132	CcSEcCtD
Risedronate—Constipation—Prednisone—asthma	3.98e-05	0.000131	CcSEcCtD
Risedronate—Vomiting—Hydrocortisone—asthma	3.98e-05	0.000131	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—asthma	3.95e-05	0.000753	CbGpPWpGaD
Risedronate—Rash—Hydrocortisone—asthma	3.94e-05	0.00013	CcSEcCtD
Risedronate—Dermatitis—Hydrocortisone—asthma	3.94e-05	0.00013	CcSEcCtD
Risedronate—Headache—Hydrocortisone—asthma	3.92e-05	0.000129	CcSEcCtD
Risedronate—Dizziness—Triamcinolone—asthma	3.89e-05	0.000128	CcSEcCtD
Risedronate—FDPS—Metabolism—PTGS2—asthma	3.89e-05	0.000743	CbGpPWpGaD
Risedronate—Dizziness—Methylprednisolone—asthma	3.89e-05	0.000128	CcSEcCtD
Risedronate—Asthenia—Betamethasone—asthma	3.83e-05	0.000126	CcSEcCtD
Risedronate—Asthenia—Dexamethasone—asthma	3.83e-05	0.000126	CcSEcCtD
Risedronate—Gastrointestinal pain—Prednisone—asthma	3.81e-05	0.000125	CcSEcCtD
Risedronate—Nausea—Prednisolone—asthma	3.8e-05	0.000125	CcSEcCtD
Risedronate—Pruritus—Dexamethasone—asthma	3.78e-05	0.000124	CcSEcCtD
Risedronate—Pruritus—Betamethasone—asthma	3.78e-05	0.000124	CcSEcCtD
Risedronate—Vomiting—Triamcinolone—asthma	3.74e-05	0.000123	CcSEcCtD
Risedronate—Vomiting—Methylprednisolone—asthma	3.74e-05	0.000123	CcSEcCtD
Risedronate—Nausea—Hydrocortisone—asthma	3.72e-05	0.000122	CcSEcCtD
Risedronate—Rash—Triamcinolone—asthma	3.71e-05	0.000122	CcSEcCtD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	3.71e-05	0.000708	CbGpPWpGaD
Risedronate—Dermatitis—Triamcinolone—asthma	3.71e-05	0.000122	CcSEcCtD
Risedronate—Rash—Methylprednisolone—asthma	3.7e-05	0.000122	CcSEcCtD
Risedronate—Dermatitis—Methylprednisolone—asthma	3.7e-05	0.000122	CcSEcCtD
Risedronate—Urticaria—Prednisone—asthma	3.7e-05	0.000122	CcSEcCtD
Risedronate—Headache—Triamcinolone—asthma	3.69e-05	0.000121	CcSEcCtD
Risedronate—Headache—Methylprednisolone—asthma	3.68e-05	0.000121	CcSEcCtD
Risedronate—Abdominal pain—Prednisone—asthma	3.68e-05	0.000121	CcSEcCtD
Risedronate—Body temperature increased—Prednisone—asthma	3.68e-05	0.000121	CcSEcCtD
Risedronate—Diarrhoea—Betamethasone—asthma	3.66e-05	0.00012	CcSEcCtD
Risedronate—Diarrhoea—Dexamethasone—asthma	3.66e-05	0.00012	CcSEcCtD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—asthma	3.62e-05	0.000691	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—asthma	3.55e-05	0.000678	CbGpPWpGaD
Risedronate—Dizziness—Dexamethasone—asthma	3.53e-05	0.000116	CcSEcCtD
Risedronate—Dizziness—Betamethasone—asthma	3.53e-05	0.000116	CcSEcCtD
Risedronate—PTGS2—Metabolism—ALOX5AP—asthma	3.51e-05	0.00067	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALOX15—asthma	3.51e-05	0.00067	CbGpPWpGaD
Risedronate—Nausea—Triamcinolone—asthma	3.5e-05	0.000115	CcSEcCtD
Risedronate—Nausea—Methylprednisolone—asthma	3.49e-05	0.000115	CcSEcCtD
Risedronate—Hypersensitivity—Prednisone—asthma	3.43e-05	0.000113	CcSEcCtD
Risedronate—Vomiting—Dexamethasone—asthma	3.4e-05	0.000112	CcSEcCtD
Risedronate—Vomiting—Betamethasone—asthma	3.4e-05	0.000112	CcSEcCtD
Risedronate—FDPS—Metabolism—PTEN—asthma	3.39e-05	0.000648	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—asthma	3.38e-05	0.000646	CbGpPWpGaD
Risedronate—Rash—Dexamethasone—asthma	3.37e-05	0.000111	CcSEcCtD
Risedronate—Rash—Betamethasone—asthma	3.37e-05	0.000111	CcSEcCtD
Risedronate—Dermatitis—Betamethasone—asthma	3.37e-05	0.000111	CcSEcCtD
Risedronate—Dermatitis—Dexamethasone—asthma	3.37e-05	0.000111	CcSEcCtD
Risedronate—PTGS2—Disease—DCN—asthma	3.35e-05	0.000639	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CHAT—asthma	3.35e-05	0.000639	CbGpPWpGaD
Risedronate—Headache—Betamethasone—asthma	3.35e-05	0.00011	CcSEcCtD
Risedronate—Headache—Dexamethasone—asthma	3.35e-05	0.00011	CcSEcCtD
Risedronate—Asthenia—Prednisone—asthma	3.34e-05	0.00011	CcSEcCtD
Risedronate—Pruritus—Prednisone—asthma	3.29e-05	0.000108	CcSEcCtD
Risedronate—Diarrhoea—Prednisone—asthma	3.18e-05	0.000105	CcSEcCtD
Risedronate—Nausea—Betamethasone—asthma	3.17e-05	0.000105	CcSEcCtD
Risedronate—Nausea—Dexamethasone—asthma	3.17e-05	0.000105	CcSEcCtD
Risedronate—Dizziness—Prednisone—asthma	3.08e-05	0.000101	CcSEcCtD
Risedronate—PTGS2—Metabolism—ALOX5—asthma	2.98e-05	0.000569	CbGpPWpGaD
Risedronate—Vomiting—Prednisone—asthma	2.96e-05	9.74e-05	CcSEcCtD
Risedronate—Rash—Prednisone—asthma	2.93e-05	9.66e-05	CcSEcCtD
Risedronate—Dermatitis—Prednisone—asthma	2.93e-05	9.65e-05	CcSEcCtD
Risedronate—Headache—Prednisone—asthma	2.92e-05	9.6e-05	CcSEcCtD
Risedronate—PTGS2—Metabolism—CARM1—asthma	2.85e-05	0.000543	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—DCN—asthma	2.81e-05	0.000535	CbGpPWpGaD
Risedronate—Nausea—Prednisone—asthma	2.76e-05	9.1e-05	CcSEcCtD
Risedronate—PTGS2—Disease—CYBA—asthma	2.76e-05	0.000526	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALDH2—asthma	2.73e-05	0.000521	CbGpPWpGaD
Risedronate—PTGS2—Disease—PARP1—asthma	2.7e-05	0.000515	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—POMC—asthma	2.62e-05	0.000501	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTT1—asthma	2.6e-05	0.000495	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS1—asthma	2.54e-05	0.000484	CbGpPWpGaD
Risedronate—PTGS2—Disease—ADCY2—asthma	2.52e-05	0.000481	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—asthma	2.39e-05	0.000457	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NQO1—asthma	2.16e-05	0.000412	CbGpPWpGaD
Risedronate—PTGS2—Disease—ITPR1—asthma	2.11e-05	0.000403	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ADCY2—asthma	2.11e-05	0.000403	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD86—asthma	2.01e-05	0.000384	CbGpPWpGaD
Risedronate—PTGS2—Disease—SMAD3—asthma	1.9e-05	0.000363	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.83e-05	0.000348	CbGpPWpGaD
Risedronate—PTGS2—Disease—PPP2CA—asthma	1.82e-05	0.000347	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTP1—asthma	1.8e-05	0.000343	CbGpPWpGaD
Risedronate—PTGS2—Disease—CCR5—asthma	1.79e-05	0.000341	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—asthma	1.77e-05	0.000339	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ITPR1—asthma	1.77e-05	0.000338	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAT—asthma	1.75e-05	0.000334	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFB—asthma	1.7e-05	0.000324	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLA2G4A—asthma	1.65e-05	0.000316	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—asthma	1.65e-05	0.000316	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPP2CA—asthma	1.52e-05	0.000291	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—asthma	1.51e-05	0.000289	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6R—asthma	1.36e-05	0.00026	CbGpPWpGaD
Risedronate—PTGS2—Disease—SERPINE1—asthma	1.27e-05	0.000243	CbGpPWpGaD
Risedronate—PTGS2—Disease—RHOA—asthma	1.23e-05	0.000235	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS3—asthma	1.22e-05	0.000232	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—POMC—asthma	1.17e-05	0.000223	CbGpPWpGaD
Risedronate—PTGS2—Disease—CD4—asthma	1.12e-05	0.000214	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—asthma	1.07e-05	0.000203	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NOS3—asthma	1.02e-05	0.000194	CbGpPWpGaD
Risedronate—PTGS2—Disease—PTEN—asthma	9.71e-06	0.000185	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—asthma	8.68e-06	0.000166	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PTEN—asthma	8.13e-06	0.000155	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—asthma	8.05e-06	0.000154	CbGpPWpGaD
Risedronate—PTGS2—Disease—EGFR—asthma	7.89e-06	0.000151	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—asthma	6.06e-06	0.000116	CbGpPWpGaD
